ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000145.1|Salinosporamide_3 # 1348 # 1620 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.637	BGC0000145.1|Salinosporamide_3 	1348	1620	-	Loose	750	23.483	adeA	44.44	3000774	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCGGCATCCGAGACGGTGAGAATCTCGCTCCACATTGGGATCATCAACGACAGGGTCAGGAAGCCGTGGCCGATCGGACCGCCGAAGGGGCTCTCTCTCACCGCCCGATCGGCATCGACGTGGATCCACTGGTGGTCGTCGGTGGCGTCGGCGAAGGTGCCGACGCGCTCCTGCGTAATCTCACTCCAGGAGCTTGGGCCGAGCACACATCCCTTCAGCGAGGGCAGTCCGGCCAGGGTGGTCGTAGTGGTCATTCACTTCCTCCGTTGA	MPASETVRISLHIGIINDRVRKPWPIGPPKGLSLTARSASTWIHWWSSVASAKVPTRSCVISLQELGPSTHPFSEGSPARVVVVVIHFLR	MQKHLLLPLFLSIGLILQGCDSKEVAQAEPPPAKVSVLSIQPQSVNFSENLPARVHAFRTAEIRPQVGGIIEKVLFKQGSEVRAGQALYKINSETFEADVNSNRASLNKAEAEVARLKVQLERYEQLLPSNAISKQEVSNAQAQYRQALADVAQMKALLARQNLNLQYATVRAPISGRIGQSFVTEGALVGQGDTNTMATIQQIDKVYVDVKQSVSEYERLQAALQSGELSANSDKTVRITNSHGQPYNVTAKMLFEDINVDPETGDVTFRIEVNNTERKLLPGMYVRVNIDRASIPQALLVPAQAIQRNISGEPQVYVINAQGTAEIRPIEIGQQYEQFYIANKGLKVGDRVVVEGIERIKPNQKLALAAWKAPAVANHASSVETKTSIAEGAQP	22.73	gnl|BL_ORD_ID|1210|hsp_num:0	1313			93	165	tigecycline; tetracycline
BGC0000145.1|Salinosporamide_5 # 2266 # 2568 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.663	BGC0000145.1|Salinosporamide_5 	2266	2568	+	Loose	1000	25.409	efpA	39.13	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGTGGCCCGCAGGCCCGGCCGGGTGTGGAAGCGATCAGGTTGGTCGCGGGCCGTGTGCAAAGCGGCGGTAGGAGATCTCGTCGAGATCGATGCTGAGGTCGACCGCGGCGGTCACGGCGTGGTCGATGAGTGCGTCGTAGACGGTCAGCAGTTCCCCGATTCCTTGTTCTGCCGGGTCCGGGGATACCACAGGATCACCTGCACACCGTCCCGCAAGCAGCCACCACGGGCGGCGTCCAGATCACCCACCGCACCCAGCGATCGCTACCCGACCGACACCAACCTCGCCCGATATCACTGA	MVARRPGRVWKRSGWSRAVCKAAVGDLVEIDAEVDRGGHGVVDECVVDGQQFPDSLFCRVRGYHRITCTPSRKQPPRAASRSPTAPSDRYPTDTNLARYH	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	18.87	gnl|BL_ORD_ID|2188|hsp_num:0	2427			63	132	rifampin; isoniazid
BGC0000145.1|Salinosporamide_6 # 3043 # 3948 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.663	BGC0000145.1|Salinosporamide_6 	3043	3948	+	Loose	650	32.3426	adeL	32.35	3000620	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCGATCCAGCGCCTGGAGAAACAACTGGACACCAAGCTGTTCTTCCGGCACCGCACCAAAGGAGTCAGCCTGACTCCCAGCGGCCGCGTCCTGCTCGACCCCGCGAAGTCGTTGCTGGCCCAGGCGCAGGAGATGCTCGCCCACAGCCGCGAGTGGCAGGGCGAGACCTGCGGAATGCTCAATGTGGCCGTTCTCCGCTCGGTCGCGCCCGATCTGGTGCCGGCTGTGATGAGCCGAGTAAAGAAGATGCGCCCTGGGCTGGCGGTCACCGTCCACGAGGGGACCATGGACGATGTTCTCGAACTGCTGCGCACGGGCACGTGTGAACTCGCCGTAGTCCCGGAGCTGCCAGGTCAGGCTCTGTCGTTCGCCCGGCTGGCGAAGGTGCTCATGGCAGCGGTCGTTGCATGGTCCGATCCGCTGGCGCCCGTGGGGCGCGCAACGCTTCGACAGTTGGCCACCCGGCGTCTCCTCGTGGCCGACCTGGACGTTGATCGCCAAGTCGGCCTGGACACCCGGACACGGCTGTTCGCCGACGCCGGCACCCCCACGCCAGAGGTGGTGCTGACATCGAGCATCGCCACGATGCTTGGCCTCGTCGGGGTCGGCGAGGGCTTCGCCCTGCTATACCGGACCGCAGCCAGCCAGTGCTACCGACAGGAACTCGCCTGGATCGACATCGTCTCCGAACGCCCGTGCGCATCCTGGCTTGGTGTGGCGACCATACCCGGCCTGGCTCTCAGCAGCCGTGCGGAGCTATTCGTTTCCCTGCTCGATGACGCTGTCCGGAGCGTCTACTGCACGACGGCGGACGACGGGGTGAGTTCCCCTGGCAGCACTGATATCTTCGATCATGGAGCCTCTTTTGCTACGGACCCCGCCGCACCCGCCTGGTCGACCTAG	MAIQRLEKQLDTKLFFRHRTKGVSLTPSGRVLLDPAKSLLAQAQEMLAHSREWQGETCGMLNVAVLRSVAPDLVPAVMSRVKKMRPGLAVTVHEGTMDDVLELLRTGTCELAVVPELPGQALSFARLAKVLMAAVVAWSDPLAPVGRATLRQLATRRLLVADLDVDRQVGLDTRTRLFADAGTPTPEVVLTSSIATMLGLVGVGEGFALLYRTAASQCYRQELAWIDIVSERPCASWLGVATIPGLALSSRAELFVSLLDDAVRSVYCTTADDGVSSPGSTDIFDHGASFATDPAAPAWST	MRVFNKVVETNSFSLAADSLGLPRASVTTTIQALEKHLQVRLLNRTTRKISLTPDGAVYYDRTARILADVADIESSFHDAERGPRGQLRIDVPVSIGRLILIPRLRDFHARYPDIDLVIGLNDRPVDLVGEAVDCAIRVGELKDSSLIARRIGTFQCATAASPIYLEKYGEPTSIEDLQKNHKAIHFFSSRTGRNFDWDFVVDDLIKSVSVRGRVSVNDGDAYIDLALQGFGIIQGPRYMLTNHLESGLLKEVLPQWTPAPMPISAVYLQNRHLSLKVKVFVDWVAELFAGCPLLGGTALPFDQKCEFACDKETGHEYTIRTLVEQHNIAEAYTLKT	89.32	gnl|BL_ORD_ID|2315|hsp_num:0	2654			90	291	tetracycline
BGC0000145.1|Salinosporamide_8 # 4754 # 8254 # -1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.680	BGC0000145.1|Salinosporamide_8 	4754	8254	-	Loose	550	27.7202	VHH-1	27.18	3007003	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	VHH beta-lactamase	GTGGGCTACCTCACCATGATCGGTTCAGACGAATTGCCGAGAAGGAGTCGCATGTCCCCCGGCTTGCAGCCAAGCGAATTCACGTTGGACCAGCGCTATCTGTGCCAGGACGGCACCGCCTACCTCACCGGCGTGCAGGCGCTGGTGCGTCTCCTGCTTGACCGTGTCCGCCACGACCGGCGTGCCGGAAACGACGCGGCGGTCTTCGTCTCCGGCTACGAAGGGTCGCCCCTGGCGGGCTACGACTTGGAGCTCGCCCGCCGGGGCCGACTGCTGGCCGAGCACGGCGTGGTGCATCGGCCCGCACTGAACGAGGAGCTTGCGGCGACGGCCGTGCTCGGCAGCCAGCTCGCTGCGGGCGTCGGCAGACAGCGCCCCGACGGTGTCGTTGGTGTCTGGTACGGCAAGGCGCCGGGTCTCGACCGCGCGGGCGACGCGTTGCGCCACGCGAACTTCGCGGGCACCGACCCGCGGGGCGGTGCCATCGCGCTCGTCGGGGACGATCCAGCGGCGAAGTCGTCGACTGTGCCGAGCGCGTCGGAGTTCGCCCTGGCGGACCTCTCAATGCCGGTCCTCGTGCCAGCAGACGCCGCCGACCTGCTCCGCTACGGCCTGCACGCCATCGAGATGTCCCGGGCGTCCGGCCTATGGTCAGCGCTCAAGATCGTGACCAACGTCGCCGACGCGGCGAGCACGGTGCCGGTCACCCCGTCCTGGCGCTTCCCGACAGTGGCTGGTGGATATCGCCACCGGCCCACGTCCCGGCTGCTCGGCGCGGAACTCGCCGCTTTGGAGGAGAGCCTTCACCGGGTCCGCCTCCCCTTGGCGGTGGAGTATCTGCGCGCCGCCGGCCTGAACGAGCTGTACGGGCACGCGGATGACCGGATCGGGATCGTGGCCGCCGGCAAGTCATATCTGGACGTCCGCCAAGCGCTGCGGACGCTTGGCATGGACGAGGAAGCTCTGCGCCGCTATCGCGTACGGCTACTCAAGCTGGCGGCGGTCTACCCCCTTGAGTCAGCCGTGGTGCGGGAGTTCGCCGCGGGGCTGGACGAGATAGTGGTGGTGGAGGAGAAACGGGGTTTCATCGAATCCGCCGTCAAGGATCTGCTCTATGGCAGCGGCGACGCGCCGGTGGTCTGCGGGAAGACGGATCCGGCGGGGCGGTCGCTGTTCCGCCCCACGGGTGAGCTGAATCCCGACGTGATCGCGGCTGGCCTCGCCCGGCGACTGTCGGCGACCGGCCGCTGCGAACCCGTGGAAGCGTGGCAGGGACGTCGGCGCCGTGACCGCATCGACCTGCCGGTGGTGGCGCGAACCCCATACTTCTGCTCCGGCTGCCCGCACAACTCGTCGACGAAGGCGCCTCCCGGTACCCTGACCGCCGGCGGCACCGGATGTTCCACCATGACCTTCTTCATGGATCCGAAGCGGGTCGGCGACATCATCGGCGTCACGCAGATGGGCGGCGAGGGTGCCCAGTGGATCGGGATGGCACCCTTCGTCGACATCGATCACTTCGTGCAGAACGTAGGCGACGGCACCTTTCACCACTCGGCCAGCCTCGCGCTGCGAGCCGCAGTGGCGGCCGGCGTCAACATTACGTACAAGGTGCTGTACAACTCTGCCGTGGCCATGACCGGTGGTCAGGACGCCGTGGGTGCCTTGCCGGTGCATCGGCTGGCCGCTCTGCTGCTGGCCGAGGGCGCGACCAAGGTGATCGTCACCTCGGAGGATCCAAAGCGGCTCGGCCGGCATCCCATGCCGGCCGGCGTCGAGGTACGCCACCGCGACGATCTGCCGCGCAGCCAGGCGGAACTCGCCGTGACTCCCGGCGTCACCGTGCTCATCCACGACCAGGAGTGCGCGGCGGTACAACGGCGTAAGCGGCGCCGCGGCCTGCGGCCGCAGCCCGCCTACAAAGTGCTGATCAACGAACGGTTGTGCGAGGGATGCGGCGACTGCGGGGCGCAGTCGAACTGCCTGTCGGTCCAGCCGGTAGATAGCGACTTTGGCCGCAAGACACGTATTCACCAGTCCTCGTGTAACGCCGACTACGCATGCCTACAGGGCCGGTGCCCATCATTCTTGACCATCGTCCCCGGCCGATCACCGCACCGCGAGCTGGCCTCGGTGCCCACGGCTAAACCATCGATGCCGCGGCAGCGCGTTGTCGGCGACTTCTCAGTGCGGATCACCGGCATCGGCGGCAGCGGCGTGGTAACCCTGGCTCAGATCATCGCCACAGCCGCAGTGCTCGACGGCAGGCACGTGCGGACGCTCGACCAGACCGGGCTGGCCCAGAAGGGCGGTGCGGTCGTCTCCGATGTCCGCGTCACCGAGCGTGCCGTCGAGTCTGCCGCACGGCTAGCGGACGGTGAATGCGATCTCTACCTAGCCACCGACCTGCTCGTCGCGGCTCAGCCCGCCAACCTCGCTGCAGCCGACACCGCCCGGACCGTCGTCGTGGCATCGACCTCGCCGGTGCCCACCGGTCAGATGGTTACCGAGGTGTCGGGCCCACGGCCCGACGTAGACGAACTGTGCTCGGCTCTCGATCGATCGAGTGCGCGCGCCACCTTCTTCGACGCCCGATCCCTCGCCTTGCGCCTGCTGGGTGACGACCAGTTCGCCAATATTCTGCAACTAGGCGCCGCCTACCAGGAGGGCGCCATCCCGCTAGAAGCGGCCAGCATCGAACAGGCGATCCGGCTCAACGGCGTTGGCGTGGAGCGCAACCTCAGCGCCTTCTGCCTCGGCCGCCTGGTGGTTGACGACCCTCAGACGGTGTCGCCGGCAGCTCCCGTAGCCCAGGAGCAACGACTGTTGCAGGGCGATGCAGCATCGTTGCGGGCGACAATCGATGCCGGCGAGGACACCCCGCTCGCGCGCCGGCTGGATGCGCTCGTGGCAGATCTCGTCGCCTACCAGGATCTGGCCTATGCCCGCGAGTTTGTGGAGTTCGTGGAACACGTACGCCGGGTGGAGGGACGGGCGGGGCCGCTCACCGCAGCCGTGGCGGGCAATCTATACAAACTTATGGCCTACAAGGATGAGTACGAGGTGGCCCGGCTCTCGCTCGATGAACGCCTGACCCACGACATAGCCGCGCAGTTCGGAGCTGGGGCGCGATACCACTACCTATTGCAGCCACCGGTTCTGAGGAAGCTCGTGCGCCGCAAGATTCGCCTCGGGCAGTGGTTCCGAGTCGTGCTCCGGCTGCTGTACGCACTGCGCAGACTGCGAGGGAGCAGGCTCGATGTCTTCGGCTACACACGCGTGCGCCGGATCGAACGGAGGCTTGTGGCGAACTATCGCAGGACGATCCTCGCCGCGTTGTCGGCGGCCAACCCCGACGACCCGGCGCTGGTAGAGCTGGCGTCTCTGCCAGACATGGTGCGTGGCTTCGACGAGGTCAAGCTCGCCAATGTGACCGAGTACCACCGGCGCCAGGAGCAGTTGCTGCAGTCGCTGCCCCACCCCGTCCAGCAGGTCGGGTAG	MGYLTMIGSDELPRRSRMSPGLQPSEFTLDQRYLCQDGTAYLTGVQALVRLLLDRVRHDRRAGNDAAVFVSGYEGSPLAGYDLELARRGRLLAEHGVVHRPALNEELAATAVLGSQLAAGVGRQRPDGVVGVWYGKAPGLDRAGDALRHANFAGTDPRGGAIALVGDDPAAKSSTVPSASEFALADLSMPVLVPADAADLLRYGLHAIEMSRASGLWSALKIVTNVADAASTVPVTPSWRFPTVAGGYRHRPTSRLLGAELAALEESLHRVRLPLAVEYLRAAGLNELYGHADDRIGIVAAGKSYLDVRQALRTLGMDEEALRRYRVRLLKLAAVYPLESAVVREFAAGLDEIVVVEEKRGFIESAVKDLLYGSGDAPVVCGKTDPAGRSLFRPTGELNPDVIAAGLARRLSATGRCEPVEAWQGRRRRDRIDLPVVARTPYFCSGCPHNSSTKAPPGTLTAGGTGCSTMTFFMDPKRVGDIIGVTQMGGEGAQWIGMAPFVDIDHFVQNVGDGTFHHSASLALRAAVAAGVNITYKVLYNSAVAMTGGQDAVGALPVHRLAALLLAEGATKVIVTSEDPKRLGRHPMPAGVEVRHRDDLPRSQAELAVTPGVTVLIHDQECAAVQRRKRRRGLRPQPAYKVLINERLCEGCGDCGAQSNCLSVQPVDSDFGRKTRIHQSSCNADYACLQGRCPSFLTIVPGRSPHRELASVPTAKPSMPRQRVVGDFSVRITGIGGSGVVTLAQIIATAAVLDGRHVRTLDQTGLAQKGGAVVSDVRVTERAVESAARLADGECDLYLATDLLVAAQPANLAAADTARTVVVASTSPVPTGQMVTEVSGPRPDVDELCSALDRSSARATFFDARSLALRLLGDDQFANILQLGAAYQEGAIPLEAASIEQAIRLNGVGVERNLSAFCLGRLVVDDPQTVSPAAPVAQEQRLLQGDAASLRATIDAGEDTPLARRLDALVADLVAYQDLAYAREFVEFVEHVRRVEGRAGPLTAAVAGNLYKLMAYKDEYEVARLSLDERLTHDIAAQFGAGARYHYLLQPPVLRKLVRRKIRLGQWFRVVLRLLYALRRLRGSRLDVFGYTRVRRIERRLVANYRRTILAALSAANPDDPALVELASLPDMVRGFDEVKLANVTEYHRRQEQLLQSLPHPVQQVG	MKKLFLLLGLLACSSATYAANLMKTSPRLKKHISGRIGVSVWDTQTDEHWDYRGDERFPMMSTFKTLACATMLSDMDNEKLDKNATAKVEERNMVVWSPVMDRMASQTTRIEHACEAAMLMSDNTAANIVLRSIGGPRGVTTFLRSIGDKATRLDRFEPRLNEANPGDKRDTTTPNAMVNTLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGGFGSRGITAMIWKENHKPVYISIYITETDLSLQARDQVIAQVSQLILDEYNTI	412.01	gnl|BL_ORD_ID|4618|hsp_num:0	5689			300	591	ampicillin
BGC0000145.1|Salinosporamide_9 # 8511 # 9299 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.657	BGC0000145.1|Salinosporamide_9 	8511	9299	-	Loose	1900	25.0238	MexI	23.94	3000808	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGGTCCTCGTCCGCAGGCCGCGGCGACGACGGTCAGGCCACCAGGCTGCTCGTCTCCAGCATCGCGTTCGGGCCGATCAGACCCATCGCCGCGAGCCTGTTGACGGCGGCCACTCGTGAGCGCACATCGAGCTTGTCGTACGTGTTGGTGAGGTGGCGCTTGACCGTGCCCTCGGAGATGGAGAGGCGGCCGGCGATCTGGGCGTTGCTCAGGCCCGCCGCGACCAGCTCGATCACCTCGAACTCCCGGCCCGACAGTGACCGCGTGCCGACCCCGGTCAGATGTTGCAGCATGCTCTTCTGCACGGAAAGCACGGCGCTGTCGCGGTTGCGGCTCACGATCCGTACGACGCTCAGCAGTTCCTCACGCGTCGAGTTCCGCGAGACGTACGCCCACGTACCCATGGCGAGGTACCGGCGCGCCAGGCGCACATTCTCGTGCATCGCCAGGATTACCAGCCGGGGCTGGCAGGTCGCGGCCAGGATCTGGCCGACCAGCCGCATGATCCCTTGGTCAGACGGGCCGACACTCAGCAGTACCACGTCTGGCGCCGTCCGTCGAACCAGGGCCGCCGCCATGGGCCCCGCCGCCGCCTGCCCGACCACCCGCAGGTCGGGCTCGCGATCGCAGATCTCGGCCATCGCCTCTCGAAAAATAGTGCTGTCGCCAAGGAGTAGAATCCGTTTCGGATTAGATTCTATGCTGGTCATTAGTCGACTCGATCCGCAATCGGAGTGGCTCTGGTCGAAGCGGCTTCAAGAATGTTTGACACGCCGCCGAAGGTAG	MRSSSAGRGDDGQATRLLVSSIAFGPIRPIAASLLTAATRERTSSLSYVLVRWRLTVPSEMERRPAIWALLRPAATSSITSNSRPDSDRVPTPVRCCSMLFCTESTALSRLRLTIRTTLSSSSRVEFRETYAHVPMARYRRARRTFSCIARITSRGWQVAARIWPTSRMIPWSDGPTLSSTTSGAVRRTRAAAMGPAAACPTTRRSGSRSQISAIASRKIVLSPRSRIRFGLDSMLVISRLDPQSEWLWSKRLQECLTRRRR	MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA	25.46	gnl|BL_ORD_ID|4683|hsp_num:0	1647			234	447	acriflavine; tetracycline; norfloxacin
BGC0000145.1|Salinosporamide_11 # 10134 # 10913 # -1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.676	BGC0000145.1|Salinosporamide_11 	10134	10913	-	Loose	400	25.409	MAB	48.0	3007180	protein homolog model	n/a	n/a	cephalosporin; penam; penem	antibiotic inactivation	class A Mycobacterium abscessus beta-lactamase	GTGTTTGTACTGTTCATCGGCGACATCGTGGGGGACGAGGGGACACGGTACCTGGTAGACCGGCTGCCCGAACTGCGTGCCCGCCACACGGTGGACCTCGTTGTGGCGAATGCCGAGAACTCGGCGGCCGACGGCTTGGGGATGGGTCGTGTGCAGGTGGAGCAACTGCTGTCCGGAGGGGTTGACGTCATCACCGGCGGAAACCACTCCTGGGACAGCCCAGAGTCGGTCGGGATGCTCAATCTGCCGCAAGTGGTTCGGCCCGCCAATGTGGACCCCGAGGTACCCGGTCGGGGCTTTGTCCATGTCCCGGTCGGCGAGGAGATGGTCACCGTACTGAACCTGGCTGATGGCTGCGCCATGGCGTCGACCAAGGCGACTGCGGGACGGGTGGGTCCCGCCTACTCGGCATGGGAGGCGGCCGACCGGCGCGGCATCACGATCGTCGACTACCACGGCGATCACGTGCTGGAAAAGCAGATCTTCGCCCACACCGTCGACGGCACCGCCGCCGCGGTCGTCGGCACGCACACCCACGAAGCCACCGACCTGCCACGGCTGCTGCCGAACGGCACGGCGTTCGTCACAGAGGTGGGCATGACGGGACCGGACGGCGGCGTGCAGGGTTTCGCTCCCGCAAACCTGGTGAACAACCTGCGGACCACCGGCAACCCGTTCGACGGGCCGATGCCCACGGTGCATCGAGCCCCGATGGTGCTCGGCGCGGTCCTGATCGAGATCGTCGGCGGTCTTGCCGCCGGCATCCAGCGGGTGCGGTGA	MFVLFIGDIVGDEGTRYLVDRLPELRARHTVDLVVANAENSAADGLGMGRVQVEQLLSGGVDVITGGNHSWDSPESVGMLNLPQVVRPANVDPEVPGRGFVHVPVGEEMVTVLNLADGCAMASTKATAGRVGPAYSAWEAADRRGITIVDYHGDHVLEKQIFAHTVDGTAAAVVGTHTHEATDLPRLLPNGTAFVTEVGMTGPDGGVQGFAPANLVNNLRTTGNPFDGPMPTVHRAPMVLGAVLIEIVGGLAAGIQRVR	MISRRALLVGGVSAVGVVAAGCSRNGNRRPAPDELASLEKDFGGRIGVYALDTGSGDTVGHRADERFLMCSTVKTFIVSAILRRRLSEPGLLDQRIQYTQSDVLEWAPITSQHVSTGMTVSELCDATLRYSDNTGANLLITQLGGPKETEKFVRSLGDNVTRMDRTEVQLNIPDGDLDTSTPQQLVANLRRLVLDEGLDSRGRDLLTDWLKRNTTGDQSIRAAVPAGWTVADKTGGGFKGETNDIAVIWPPGRAPIVMAVLTVPEDPTSTKGKPTIAAATRIVLRAFGA	89.62	gnl|BL_ORD_ID|4810|hsp_num:0	5799			495	570	ceftazidime; cefuroxime; amoxicillin; cefalotin; ticarcillin
BGC0000145.1|Salinosporamide_12 # 11151 # 11918 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.661	BGC0000145.1|Salinosporamide_12 	11151	11918	+	Loose	350	27.335	vanO	30.95	3002913	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGACGAACGGTGGGCGCCTATCGGGAAAAGTAAGTCTGATCACCGGCGCCGCGCATGGCATAGGCCATGCCACGGCTGTGTGGTTCGCCCGCGAGGGAGCCCGGCTGGTGGTCAGCGACGTGGACGGTGCCGCACTGGAGAAGTGCCACGCCGAACTGGCCGAGTCCGGAGCCGAGGTGACGACGGTGATCGCCGACGTCTCAGACGCCACCCAGGCACACCGCATGGTTCAGACGGCCGTCGATGTCTACAACCGGCTGGACGTCGTGGTCGCCAACGCTGGCGTGATCCCTCTGCACGAGATCACCGAGGCGACCGAGCAGGACTGGGATGAGGTCATGGCCGTCGATGGCAAGGGCATGTTCCTCACGTGCAAGTACGGCATTGACGCCATGCTGGCCACGGGCGGCTCGATCGTGTGCCTTTCATCTATCTCCGGCGTCGCTGGCCAGCGGGGGCAGAGCACGTACGGCCCGGCCAAGTTCGTGGCTTCCGGGCTCACCAAGCACTTGGCCGTCGAATGCGCACGACACTGCATCCGGGTCAACGCGGTCGCTCCCGGGACTATCCGCACCAACCGGGTCCGCCGGCTCGAAGAAGAACCGGGCGGTCCGGAGTACCTGGAGGACATCGTCCGGCTCCATCCAGCCGGACGCCTGGGCGAGCCGTCGGAGGTGGCAGCCGCGATCGGATTCCTGGCCTCCGACGAGGCCTCGTTCATCACGGGTGTAGTACTTCCCGTCGACGGAGGTTACCTCGCGCAGTGA	MTNGGRLSGKVSLITGAAHGIGHATAVWFAREGARLVVSDVDGAALEKCHAELAESGAEVTTVIADVSDATQAHRMVQTAVDVYNRLDVVVANAGVIPLHEITEATEQDWDEVMAVDGKGMFLTCKYGIDAMLATGGSIVCLSSISGVAGQRGQSTYGPAKFVASGLTKHLAVECARHCIRVNAVAPGTIRTNRVRRLEEEPGGPEYLEDIVRLHPAGRLGEPSEVAAAIGFLASDEASFITGVVLPVDGGYLAQ	MSRLKVGVIFGGASEEHPVSIKSAREVARSLDTEKYEPFWIGITTGGEWKLCDGPDADWENRSARPAVLSPDRSVHGLLVMEQGGYETVRLDLVFPVLHGKLGEDGAIQGLLELAGIPYVGCDIQGSAVCMDKALAYIVAKSAGIATPSFWVVAENEKVDADHLRYPVFVKPARSGSSFGVSKVTREDELPNALSAARQYDSKVLIEEAVAGSEIGCAVMGELFGLITGEVDRVDLSHGFFRIHQEDSPETGSENSTFIVPADISDESRRLVQETAKAIYRTLGCKGLARVDMFLTDDGRVVLNEVNTMPGMTSYSRYPRMMAAAGLPISDMIDRLISMTMHGKKR	73.70	gnl|BL_ORD_ID|1607|hsp_num:0	1754			675	921	vancomycin
BGC0000145.1|Salinosporamide_14 # 13250 # 14026 # -1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.690	BGC0000145.1|Salinosporamide_14 	13250	14026	-	Loose	920	26.5646	OpmD	55.56	3000809	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGCTAAAGAGCTGGGCTGCCGCGGCGGCTGGATGGGCTACTTCGGAACCCGGTCGGCCCCGCTTGGTGCGGCGTCACCCGAGGTGGTGACCGCGGCGTTCTTCAATTTCCACCCGCAGATGGTTGCCAAGGCGGTTCCGCAAGTCTGGTCCGTGGCCTCGCCAGAGCGTTTTCTACAGGCGCGGCTGGAGATCGTCGACGCTGCGCTGCGCCGCATGCTTGGCGCTGATGTGGCCGGGCTCGAGGAGATGGTCACGCTTGCCGCGTCCGCCGCTGCGGGCGTGTCTCCCGGCGGCCGCGTACTGGGTGCTGCCAACCAGGCGCTTCCACCGCCGGTCGAGCCGCATCTCGCGCTCTGGCAGTCCTGCTCGACGCTGCGAGAATCGCGTGGTGACGGCCATGTGGCGGCGCTCGTGGCTGCGGGCCTGGCACCGTGCGAGGCGCTGGTCTTGTTCACGGCCGACAAGGGCCTCGACCCGGCATACATGCGCCGGATGCGCGGATGGTCCGAACAGGAGTGGAAGGAGGCCGAAGCCGCGCTCGTCGATCGTCGTCTGCTCACCGGCGGCGGCCTCACCGTAGCCGGGCGGGAGCTTCGTGCGGAAGTCGAACGGTGGACGGACATGGCAGCGGCGGCCCCGTGGCAGGCTCTGGGAGCCGGTCCCACCGCCAGGCTCCGCGACCTCATGACGCCGGTGGTGCAGCGCCTCAGCGAGCTGAACGAGTCCATGAAGGTAAACCCCATGGCGCTGAATCCGGCGGAGATTGTGGCGTAG	MAKELGCRGGWMGYFGTRSAPLGAASPEVVTAAFFNFHPQMVAKAVPQVWSVASPERFLQARLEIVDAALRRMLGADVAGLEEMVTLAASAAAGVSPGGRVLGAANQALPPPVEPHLALWQSCSTLRESRGDGHVAALVAAGLAPCEALVLFTADKGLDPAYMRRMRGWSEQEWKEAEAALVDRRLLTGGGLTVAGRELRAEVERWTDMAAAAPWQALGAGPTARLRDLMTPVVQRLSELNESMKVNPMALNPAEIVA	MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR	52.98	gnl|BL_ORD_ID|450|hsp_num:0	442			960	1014	acriflavine; tetracycline; norfloxacin
BGC0000145.1|Salinosporamide_17 # 20636 # 22534 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.665	BGC0000145.1|Salinosporamide_17 	20636	22534	+	Loose	1000	115.546	almE	28.37	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACGACCGCATCGACACTGCACGGCGGTTTTGTCGCCCACGCAGCCGCGAATCCGGACACGCTGGCCGTAGCGTCCGACGCCGGCGTGATGACCTACGGTCGGCTTGACGAGACCTCGGCGGCGCTGGCCGAGCGGCTGTCTGCCTTGGGTGCTGGCCCGGGTGTTCCGATCGGGGTCTGTATCGAACGCACGCCGGACCTGCTCGTCGCTATCCTCGGCGTGCTGCGCGCGGGCGCCTGCTATCTGCCGCTCGATCCTCAATATTCAGCGCGCCACCTCGGCTTCATGGTGGCCGACAGCGGGACCCGCCTGGTCGTTACCACACGATCCTCTCGGGACGCGTGCCCGGACGGCTGCACCGCGCTCGTCCTGGAGGAATCCGAGGCGATAGCCGACCCGCCGCCAGTGGCCGCGGTTCCGGACGATTCTGCCTACGTCATATATACCTCCGGCTCGACCGGCACGCCCAAGGGGGTGCCGATCCGGCACAGCAGCTGCGCGGCGATGCTTGCCGAGGCGGACCGAATTTTCGAGGGCTGTGACATGAGCGGTATCGCCGCCGTCACCTCGGTCTGCTTCGACCTGTCAGTGCTGGAGATCTTCTCCGCCCTCAGCCGTGGCCGGACGCTCGTCCTGGTGAATAGTGCCAGCCACCTTCCGGAGAGCTCCCATGTCGAACGGGTGACGCACGTCAGCACGGTCCCGTCCGCAATGACCAGCCTGCTTGACGCGCAAGCCGTTCCGGCCGGCCTGCGGAACGTGGTGCTCGGCGGCGAACCCGTACGTCGGAGCCTGGTCGACCGGATCTACCGCGAGACCAACGTCGACTTCGTCTTCAACGGATACGGCCCGACGGAAGGCACGGTCTTCTGTACCTTCAAGCCCGTATCCCGCGACGAGGCCGGCGAGCCGTCGATCGGTACGCCATCCCTGACCGCTCGCGTCTATGTGCTCGACGAGAAGCTGCGGCCGTCGGCCGTCGGCGAGTCGGGTGAGCTGTACCTCGGCGGTGCCGGACTTACCTGGGGCTACCTCAACCGGCCCGGGCTGACTGCGGAACGGTTCGTACCTGATCCGCAGGTGGCGGGTGAACGCATGTATCGCACCGGCGACATCGCTCGGCTCAACGAAGCAGGTGAAATCGAGTTCGTGGGACGCTCCGACCTTCAGGTGAAGGTCCGCGGGTACCGCATCGAGCTAGAAGAGGTCGAGGCACGACTAACCGAATGCCCCGAGGTGCGGACGGCTGCGGCCGTCGTCCGTGAGCAGACGCCGGGTACGAGAGCCCTGACCGCGTACGCGGTTCCGGCGAGTGGAGCACCCGACGGCGACGGGCCCTGGCTCGACGCCGACCTGCAGGCAACGATCAAGCAACAGCTCGGTGCGCTGTTGCCCGGTTACATGGTTCCCGAAACGATCGTCTTCCTGCCCGCGCTCCCGCTGTCGCCAGTTGGGAAGCTGGACCGCACGGCGCTACCGGCACCACCCGTTGTCGATGTGCTGCCCTCGGGGGACTCCGCCACCACCGACACCGAACAAGCGCTTGCCGAGATCTGGGGTGCACTGCTGGACCGGACTCCGCAGTCCATCGGCATCCGCGACACATTCTACGACCTCGGCGGCAACTCTTTGTTGTTGGTGCGGCTCGCGAAGCGAATGGGTCAGCGCTTTCACCGCAAGGTCGGCGTGGCGGACCTGTTCCGGTTCCGCGACATCGGCTCGCTCGCCAAGTGGCTGGACGACGAGAGCGGAAAGAGTCCTGAGGACATCGAGCAGGCACGACGCCGTGCCAGCACCAGACGCTCGGTGGTGCGCGGCCACAGCAGATCACCGAGCACTCGAACCGACCCGACCGTCAAGAACACGCCCGCATCAAATGGAGGCCCACATCCATGA	MTTASTLHGGFVAHAAANPDTLAVASDAGVMTYGRLDETSAALAERLSALGAGPGVPIGVCIERTPDLLVAILGVLRAGACYLPLDPQYSARHLGFMVADSGTRLVVTTRSSRDACPDGCTALVLEESEAIADPPPVAAVPDDSAYVIYTSGSTGTPKGVPIRHSSCAAMLAEADRIFEGCDMSGIAAVTSVCFDLSVLEIFSALSRGRTLVLVNSASHLPESSHVERVTHVSTVPSAMTSLLDAQAVPAGLRNVVLGGEPVRRSLVDRIYRETNVDFVFNGYGPTEGTVFCTFKPVSRDEAGEPSIGTPSLTARVYVLDEKLRPSAVGESGELYLGGAGLTWGYLNRPGLTAERFVPDPQVAGERMYRTGDIARLNEAGEIEFVGRSDLQVKVRGYRIELEEVEARLTECPEVRTAAAVVREQTPGTRALTAYAVPASGAPDGDGPWLDADLQATIKQQLGALLPGYMVPETIVFLPALPLSPVGKLDRTALPAPPVVDVLPSGDSATTDTEQALAEIWGALLDRTPQSIGIRDTFYDLGGNSLLLVRLAKRMGQRFHRKVGVADLFRFRDIGSLAKWLDDESGKSPEDIEQARRRASTRRSVVRGHSRSPSTRTDPTVKNTPASNGGPHP	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	113.67	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1629	colistin A; colistin B
BGC0000145.1|Salinosporamide_18 # 22531 # 24324 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.672	BGC0000145.1|Salinosporamide_18 	22531	24324	+	Loose	750	58.9214	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	23.49	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGAGCGAAGCCGTTGAGCGGAACTACGATCCGGGAGACGTCGCCATCATCGGCGCCTCGTGCAGATTCCCTGGCGCACGAAACAAGGAACAGTACTGGGACAACCTTCTCCATGGGCGCGAGGGCGTGACCTTTTACGCCAAGGACGAGATCGAGGTGGACGAGACGCTCATCAACAGTCCGGCGTACGTGCGGGCCACCGGAGCACTGGACGGATACGACGAGTTCGATCCCGCCGTGTTCGGTGTTAGCGATCGAATGGCGGCGGCGATGACTCCCGAGCACCGGGTCTTCCTGGAGGCATCCTGGGAGGTGATGGAGGACGCCAGCTACGACCCCGAGCGGGTCCGCGGCGAGGTGGGCGTCTACGCCTCGACCAACCCGCAGAGCGCGGCCCTCTACAGCTCACCACCGGACTGGGTATCGGCCGGCCCGGAGGTGATGGACCGCAGTAACGCATGGCTACCGGACACGATCACCTCCAACGTCTTGTACTACCTCGGCCTGACCGGTGAGGCGGTCACCGTGACCGCCGTGTGCTCGGGCTTTCACTATGCGGTGCACCTCGCGTGCCAGTCACTTCTCCTAGGCCAGACTGATATGGCGATCGCGGGCGGCGTCATGGTTCGGCTGCCCCAGCGCCGCGGCTATCTGTGGGAGGAGGGTCGAATTCTGTCCCGCGACGGCCACTGCCGCCCCTTTGACGCGAACGGCACCGGATCGGTACTGGCCAGCGGAGTCGCGGTGGTCCTACTCAAGCCGCTGCCACAGGCCGTCGCCGACCGCGACCACATCTATGCAACGGTCAAGGGAACGGCCATCAACAACAACGGCATCAGTGCCATGGCGTACGGCCTCGCGCAGCCTGAACGGCTCAGCGCCTGCATCGCCGGTGCGATGCAGGCCGGCGATGTGGCGCCCGAAACGGTGTCCATGTACGAGGCCAATGGGTTCGGCATGCCCATCACGGACTCGCTCGAGGTGCACGCCGCCCATCTGGCGTTCGGGAAGCAGTCCGGCACCTGCTCGATCGGGGCGGTCAAGGGCAATATCGGGCACGCCGGCGTGGTTGCCGGTGGCTCCGGCGCGGTCAAGGCGGCGTTCGCGCTGTACCACCGCAGTCTCCCGCCCACCATCAACCTGACCGAGCTCAACGAAGAAATCGACTTCCCGCGTACTCCGTTCGTCCCGCAACTGGAGCCCGCCGCCTGGCAGCCGGAGTGCGGCATCAGACGGGCCGGCATCACCGCGCTCGGCGGCGGCGGGTACAACGCGCACCTGGTCCTCGAGGAGCCGCCGCGTCCGGTCGAACGGGAGCCCGAGAACCGCCGGCCCCGGATCGTCACGCTGTCGGCGCTCGACGACGCCGCGGTCTCCCGCCAACGCGCGGCCCTGTCCTCCTGGCTCGCTGAGCATTCCGATGCTCGGCTCGACGACATCGCCTATAGCCTCAACCTCGGGCGTAAGGCGCTGCCATCCCGATGGGCGGCCGTCATCAGCACCCGCGACGAACTGCTCGAGGTGCTGTCGGGCGACGGCAAGAGCGGTCGGGTGTCTCGCTTCGGCCAAGAGCGCCGCGCCGACCTGGCGCGTTTTCGGCGCACCGAAGACGGACTCGCTCTCGGCAGCGGGGACGAGATGCGCGACGTTCAGGCGCTGACCGAGCTCGCCGCAGCATGGGTGCAGGGGGAACGCGTGAACTTCGAGGTGTTGCACGCCGACGAACGCAGCCACCGCATTTCGTTGCCCAACTATCCGTTCGCGCGCCGACGGTTCTGGCGCACCGACTGGTGA	MSEAVERNYDPGDVAIIGASCRFPGARNKEQYWDNLLHGREGVTFYAKDEIEVDETLINSPAYVRATGALDGYDEFDPAVFGVSDRMAAAMTPEHRVFLEASWEVMEDASYDPERVRGEVGVYASTNPQSAALYSSPPDWVSAGPEVMDRSNAWLPDTITSNVLYYLGLTGEAVTVTAVCSGFHYAVHLACQSLLLGQTDMAIAGGVMVRLPQRRGYLWEEGRILSRDGHCRPFDANGTGSVLASGVAVVLLKPLPQAVADRDHIYATVKGTAINNNGISAMAYGLAQPERLSACIAGAMQAGDVAPETVSMYEANGFGMPITDSLEVHAAHLAFGKQSGTCSIGAVKGNIGHAGVVAGGSGAVKAAFALYHRSLPPTINLTELNEEIDFPRTPFVPQLEPAAWQPECGIRRAGITALGGGGYNAHLVLEEPPRPVEREPENRRPRIVTLSALDDAAVSRQRAALSSWLAEHSDARLDDIAYSLNLGRKALPSRWAAVISTRDELLEVLSGDGKSGRVSRFGQERRADLARFRRTEDGLALGSGDEMRDVQALTELAAAWVQGERVNFEVLHADERSHRISLPNYPFARRRFWRTDW	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	143.51	gnl|BL_ORD_ID|1968|hsp_num:0	1943			435	1239	isoniazid
BGC0000145.1|Salinosporamide_19 # 24321 # 25598 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.643	BGC0000145.1|Salinosporamide_19 	24321	25598	+	Loose	900	27.335	msrF	30.0	3005087	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic target protection	msr-type ABC-F protein	GTGACCGCCGCGGACACAGGTCGCGTGGGTTCAGGCGAAAGCCAAACGCCGGCCCACACCGTCGACCTAGCCGACCCCGCCACCTTCGCCAATCACGACCTGACCGGTTTCTGGCAACAGCTGCGCGACGAGGAGCCGATCCACTGGAATCCCCCGACAGCCGGACGTCGAGGCTTCTGGGTGGTGTCGCGATACGCAGACATTCTCGACGTCTACCGCGACGACGTCACCTTCACCTCAGAGCGCGGGAATGTGCTCGTGACGTTGCTGGCGGGCGGTGACGCGGGCGCTGGCCGGATGCTGGCGGTCACCGACGGGCCGCGTCACGCGGAGTTGCGCAAGCTGCTGTTGCGGGCATTGGGGCCGCGCGTACTCGCGCCAGTCTGCGCCGCGGTGCGGACCAACACCCGGCAGATGATCCGCGAGGCAGTCACCAAGGGTGAGTGCGACTTCGCGTCCGACATCGCCAGCCGCATTCCGATGATGACGATCTCCAACCTGCTGGGGGTCCCCGACGCGGACCGTGCCTTCCTGCTGAGTCTGACGAAGACGGCGCTGAGCGCCGACGACGAAAGCATCAGCGAGACCGAGTCCGCGATGGCACGCAACGAGATCCTGCTCTACTTCCAAGACCTCATGGAGTTCCGGCGCGACCACCCCGGCGAGGATGTCGTGAGCATGCTGGTGAACAGCAGCATCGACGGAGCGCCCCTTTCGGACGACGACATAGTGCTCAACTGCTACAGCCTGATCATCGGCGGCGACGAAACGAGTCGGCTAACCATGATCGATAGCGTGAATACGCTGGCTGCACACCCCCAGCAGTGGAGGCGACTCAAAGATGGTCAATGCGAGATCGACAAGGCCGTGGACGAGGTACTGCGCTGGGCCTCACCCTCGATGCACTTCGGACGGGTGGCAGCGCGGGACACCATTCTTCATGGAGTGCGGATCCGGGCGGACGACATAGTTACCCTCTGGCATGCCTCCGGCAACCGCGATGAGCGGGTCTTCCATCGGCCGGAGGTGTTCGACCTGGGCCGTACACCCAACCGGCACCTCTCGTTTGGGCACGGGCCTCACTACTGCATCGGTTCCTACCTTGCCAAGGTGGAGATCTCGGAGCTGCTGATCGCTCTGCGGGATCTGACATCGGGTTTTGAGACAACAGGCGAGCCGCAACGGATCCGGTCGAACCTGCTCACTGGCTTCGCCACCATGCCAGTCCGCTTCGTTCCTGATCGTGCAGGGCTCGCTCGCGACGCGCTGGATGGGTGA	MTAADTGRVGSGESQTPAHTVDLADPATFANHDLTGFWQQLRDEEPIHWNPPTAGRRGFWVVSRYADILDVYRDDVTFTSERGNVLVTLLAGGDAGAGRMLAVTDGPRHAELRKLLLRALGPRVLAPVCAAVRTNTRQMIREAVTKGECDFASDIASRIPMMTISNLLGVPDADRAFLLSLTKTALSADDESISETESAMARNEILLYFQDLMEFRRDHPGEDVVSMLVNSSIDGAPLSDDDIVLNCYSLIIGGDETSRLTMIDSVNTLAAHPQQWRRLKDGQCEIDKAVDEVLRWASPSMHFGRVAARDTILHGVRIRADDIVTLWHASGNRDERVFHRPEVFDLGRTPNRHLSFGHGPHYCIGSYLAKVEISELLIALRDLTSGFETTGEPQRIRSNLLTGFATMPVRFVPDRAGLARDALDG	MEQICFELENVEVTFLDKKILEIDRLAVHQFDRIGIVGKNGAGKSTLLKILGGIIKPTRGKVNRYIDYGYFEQVESPKVSMADPRLLGKLNVKVDSNNLSGGELTRLKIAQLFTDYYESLLIDEPTTHLDQDGISFLIDKLKYYYGALVLISHDRNLLDELVTTIWEIDDGMIKVYSGNYSEYLRQKKVEREQQAHDFDLYLKEKNRLEKAAKEKMNKAEKIANSSSMSKKESKAKANRMFESKSKGTSQKSLQRAAKAVEKRIEQLEVVDAPKEIHTIQFHQTHSTPPLHNKFPILGDRLTLQAGDKTLLEETSFQFPLGKTIAITGNNGSGKTTLIHHIIQKGEGITISPKAVIGFYEQMGYQFNEDKTVLSYMKARSDYDESKIRSVLHAMNFNGNDLKKNVRYLSGGEATRLVLCQLFLGRYNILILDEPTNFLDIFCIEALERFIEEYEGTIILISHDKKFVDHVSDTIYKIENKKLNLVN	87.45	gnl|BL_ORD_ID|2804|hsp_num:0	3821			966	1086	erythromycin
BGC0000145.1|Salinosporamide_20 # 25595 # 25819 # 1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.680	BGC0000145.1|Salinosporamide_20 	25595	25819	+	Loose	880	23.8682	arlS	35.71	3000839	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAGACAAATGATCGCCAACCCCCTCGATCCGGGCGACGGCACGTGGCTGGTCGTGGTTAACGACGCCGGCCAACACGCGCTGTGGCGGCCCTTTCTGGATATGCCGCCCGGCTGGCGTGTCGTCCTACGCGACGCCGACCACGACGCGGCCCTTGACTACGTCGAGCGCAACTGGACTGCCCTGCAACCCGCGGGCCACAGCGAACCGGGGGCGACGAGGTAA	MRQMIANPLDPGDGTWLVVVNDAGQHALWRPFLDMPPGWRVVLRDADHDAALDYVERNWTALQPAGHSEPGATR	MTKRKLRNNWIIVTTMITFVTIFLFCLIIIFFLKDTLHNSELDDAERSSSDINNLFHSKPVKDISALDLNASLGNFQEIIIYDEHNNKLFETSNDNTVRVEPGYEHRYFDRVIKKRYKGIEYLIIKEPITTQDFKGYSLLIHSLENYDNIVKSLYIIALAFGVIATIITATISYVFSTQITKPLVSLSNKMIEIRRDGFQNKLQLNTNYEEIDNLANTFNEMMSQIEESFNQQRQFVEDASHELRTPLQIIQGHLNLIQRWGKKDPAVLEESLNISIEEMNRIIKLVEELLELTKGDVNDISSEAQTVHINDEIRSRIHSLKQLHPDYQFDTDLTSKNLEIKMKPHQFEQLFLIFIDNAIKYDVKNKKIKVKTRLKNKQKIIEITDHGIGIPEEDQDFIFDRFYRVDKSRSRSQGGNGLGLSIAQKIIQLNGGSIKIKSEINKGTTFKIIF	16.41	gnl|BL_ORD_ID|165|hsp_num:0	182			96	180	ciprofloxacin; acriflavine; norfloxacin
BGC0000145.1|Salinosporamide_21 # 25819 # 26679 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=10bp;gc_cont=0.674	BGC0000145.1|Salinosporamide_21 	25819	26679	+	Loose	600	40.817	EstT	28.33	3007459	protein homolog model	n/a	n/a	macrolide antibiotic; glycylcycline; tetracycline antibiotic	antibiotic inactivation	macrolide esterase	ATGCCGTTTGCGTTCGCCAACGACATCAGGTTGCACTACGAATTGCATGGCACGGGCGATCCCGTGGTGCTGGTCAGTGGTGCCGGCGTATCCGGGAAATCCTGGCTGATCCATCAGGGGCCGGCACTGCTGGAGAACGGCTACCGGGTCTGCGTCTACGACAGCCGCGGCCAACCACCCAGCGATGAGTGCATCAGCGGCTTCGTCGTGGAGGATCTGGTAGCCGACCTCGCAGCCCTACTGGAGTTCCTCGACGCTGGCCCGGCCCGCCTCATCGGCACCTCGACGGGTGCCTACGTGGTGCAGGAGCTTGCCCTGCGTCGACCGGAGCTGGTTCGGCAGGCGGTGTTGATGGCCAGCCGGGCCCGTCCCGACGTGTTACGGACACAGCTGGCGCGTGCCGAGATCGAGTTGGGTGAGTCTGGGGTGACGCTGCCGTCCTCGTATCGCGCGGTCGTTCGCGCGCTCCAGATGCTCTCGCCACGATCGATGGACGACGAGTCGTCGATCCGCGACTGGCTGGCCCTGCTCGAGCTCGCCCCGCCCGACGGAGCGGGAGTACGGCATCAGCTCGCTCTCCAACCGATGCCGGACCGCCGCGCCGCCTACGCCGAGATCGCGGTGCCCTGCCACGTCGTGTCGTTCGCGGATGACTTGATCGCGCCGCCCGGGTACGGCGAGGAGCTGGCGGGGTGTATTCCCGGCGCCACCTTCGACTTGGTCGGGGACGCCGGCCACTTCGGCTACCTGGAACGGCCCGAGGAGGTCAACCACATCATCGCCAAACATTTCGCGGGCATCGGCGCCCGCCTCACCGGACACAACCCAGACACCAGGAGGAGTGCGCCATGGGCCAGCTGA	MPFAFANDIRLHYELHGTGDPVVLVSGAGVSGKSWLIHQGPALLENGYRVCVYDSRGQPPSDECISGFVVEDLVADLAALLEFLDAGPARLIGTSTGAYVVQELALRRPELVRQAVLMASRARPDVLRTQLARAEIELGESGVTLPSSYRAVVRALQMLSPRSMDDESSIRDWLALLELAPPDGAGVRHQLALQPMPDRRAAYAEIAVPCHVVSFADDLIAPPGYGEELAGCIPGATFDLVGDAGHFGYLERPEEVNHIIAKHFAGIGARLTGHNPDTRRSAPWAS	MKKKLLWILILGLIIISCKQRKTEMKEKIIKTNGIELCTESFGNKKNPAILLVAGATVSMLYWDTEFCQQLSEKGFFVIRYDNRDVGKSTNYEPGSTPYDIVDLTNDAISILDGYKIDKAHFVGISLGGLISQIASIKFADRVNSLTLMSSGPWGDSDPTIPEMDTSILDFHSKAGTVNWTNEDSVVNYLIQGAELMSGKKQFDKQRSEKLIRAEFNRANNYISMFNHAASQGGGGEEYWNRLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHVDDWKSIIDGIEKHIND	93.46	gnl|BL_ORD_ID|4956|hsp_num:0	5948			93	453	tigecycline
BGC0000145.1|Salinosporamide_22 # 26667 # 28049 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.678	BGC0000145.1|Salinosporamide_22 	26667	28049	+	Loose	660	41.2022	MexS	22.85	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGCCAGCTGACCGACGCCGTGCTCAGCAACGCGACGGCGGCAGAGATCGCCGCCGCTCCGCTACCCGAGGAGTACTTCGCCGCCCACCTGCGGGTCGAAGACGCCACGATGTTCGAGGGCGTCGTGGACAAGGACGTCCGCAAGTCGCTGCGGCTCGGTCACGTTCCAATGCCCGAGCTGGCTCCGGACGAGGTCCTCGTCGCGGTGATGGCGAGCGCGGTCAACTACAACACCGTGTGGTCGGCGATGTTCGAGCCGATGTCCAGCTTCCGCTATCTGAAGGGGCTCGCCCGGCAGGGTGGCTGGGCGAAACGGCACGACCAACCCTTCCACGTGGTCGGCTCCGACTGCGCTGGGGTGATCGTGCGCACCGGCTCCGGCGTTCGCCGCTGGGAGATCGGCCAGCACGTCGTGGTGAGCCCGGCGTACGTGGACGACCAGGAGCCCACCACGCACGCCGACGGAATGCTCGGCGGGGACCAGAAGGCGTGGGGTTTCGAGACAAACTTCGAGGCGCTGGCCGAGTTCACGGTGGTCCGGGCCACCCAGCTGATTCCCAAGCCCGCCCACCTCACCTGGGAGGAGGCCGCGAGCGTCCCGCTGTGCGCGGGAACCGCCTACCGGATGCTGGTCAGCGAGCGCGGCGCGAACATGAAGCAGGGAGACGTCGTGCTCGTCTGGGGTGCGGCCGGCGGTCTCGGCGGCTACGCAGTGCAGTATGTGCGTAACGGTGGCGGCATCCCGGTGGCCGTCGTCGGGTCCGAGCGCAAGGCGGAGGCAATGCGCCGACTCGGCTGCGAGGTGATTCTCAACCGGACCGAGATCGGCATCACTGACGAGATCGCCGACGACCCGAAGCAGGTGATCAGAGCCGGCGTGCGGCTCGGTGAAATGATCAACGAACAGGTGGGCCGGGCTCCGGATATCGTCTTCGAGCACATCGGACGGCCCACCTTCGGGATATCGGTGTTCGTCGCACAGCGCGGCGGCACCGTAGTGACGTGCGGCTCGAGCGCCGGGTATCAGCACAGCTTCGACAACCGCTACCTGTGGATGCGCCTCAAACGGATCATCGGCAGCCACATCGCCAACCTCCAAGAGTACTGGGATGCGCACCGCCTGTTCGAACTCGGTCACATCGTGCCGACCATGTCGGCGGTCTATCCGTTGACGGACGTCGCGGCCGCCTGCCGTCTCGTGCAGGCCAACCAGCAGATCGGCAAAATCGCCGTGCGCTGCCTGGCACCCCGCGCCGGGCTCGGGGTGACCAACCCCGAGTTGCGCGAGCGCATCGGCGAGGACCGCCTGAACCCGTGGCGCGGCCTCACCACCGGCTCTGACGGTGCCGAGTTCGGAGGACAGCGTGACGACCCGGCCTAA	MGQLTDAVLSNATAAEIAAAPLPEEYFAAHLRVEDATMFEGVVDKDVRKSLRLGHVPMPELAPDEVLVAVMASAVNYNTVWSAMFEPMSSFRYLKGLARQGGWAKRHDQPFHVVGSDCAGVIVRTGSGVRRWEIGQHVVVSPAYVDDQEPTTHADGMLGGDQKAWGFETNFEALAEFTVVRATQLIPKPAHLTWEEAASVPLCAGTAYRMLVSERGANMKQGDVVLVWGAAGGLGGYAVQYVRNGGGIPVAVVGSERKAEAMRRLGCEVILNRTEIGITDEIADDPKQVIRAGVRLGEMINEQVGRAPDIVFEHIGRPTFGISVFVAQRGGTVVTCGSSAGYQHSFDNRYLWMRLKRIIGSHIANLQEYWDAHRLFELGHIVPTMSAVYPLTDVAAACRLVQANQQIGKIAVRCLAPRAGLGVTNPELRERIGEDRLNPWRGLTTGSDGAEFGGQRDDPA	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	135.69	gnl|BL_ORD_ID|1039|hsp_num:0	1041			45	759	ciprofloxacin; trimethoprim; chloramphenicol
BGC0000145.1|Salinosporamide_24 # 30256 # 30951 # -1 # ID=1_24;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.638	BGC0000145.1|Salinosporamide_24 	30256	30951	-	Loose	500	29.261	APH(3')-IIc	28.99	3002646	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	GTGGCCGCCACGTTCGCTGGTGGCGTCCTGCTCGCTGGCGACCGTCGTACGACCATGGGGAACCTGATCGCCGGCCGGGACGTGGACAAACTCACGATCACGGACGACTATTCGGCGGTCGGTTTCGCCGGCACGGTGGGCATCTCCATTGACATGACTCGGTTGTTTGTCGTCGAGCTGGAGCATTATGAGAAGATCGAGGGCGTCCCGCTCTCACTGGAGGGCAAGAGCAACCGGCTCGCTGCCATAGTCAAGGGAAACCTCCCCATGGCCAACGCGGGCATGGTTTCTATCCCGCTGTTCATCGGCTACGATCTCGAGGCATCCGATCCTGCGAGGGCCGGCCGGATCGTGTCGTTCGACGCAATCGGCGCCCGCTATGAGGAAAAGTCCGGCTACCAGTCGATCGGCTCGGGCTCCCCCTTCGCTAAATCGTCTCTGAAGAAGCTACACGACCCCGGTTCCGATGATGCGGCTACCCTGAGTGCCCTGATCGAGGCGCTGTACGATGCCGCCGATGATGATTCGGCCACCGGCGGCCCCGACATGGTCCGCCGCATTTTCCCCACGGCCATCCGCATCACGGCCGAGGGCGCCTACCGATACACAGAGGAGGAACTCGCGGCAGTCGCCGACGCCGTCGTCGCCCGGCGTAGTGCCGACGAGCCCGGCGTCCGAAGCTTTACCGCGTCCTGA	MAATFAGGVLLAGDRRTTMGNLIAGRDVDKLTITDDYSAVGFAGTVGISIDMTRLFVVELEHYEKIEGVPLSLEGKSNRLAAIVKGNLPMANAGMVSIPLFIGYDLEASDPARAGRIVSFDAIGARYEEKSGYQSIGSGSPFAKSSLKKLHDPGSDDAATLSALIEALYDAADDDSATGGPDMVRRIFPTAIRITAEGAYRYTEEELAAVADAVVARRSADEPGVRSFTAS	MEASNPFTDGLRLPRAWQEALADAHIERQSIGVSRADVARVHRPGQTDAFLKSEVIDAFSELGDEIARLRWLQAQGQSAPTVIATTEEGGRRWLLMSALPGRDLASSPELAPRRVAELLADALRGLHAVPVANCPFDQQLASRLQAAQARVEAGLVDADDFDDERLGQSPQQVFAELRATRPAHEDLVVSQGDACLPNLTVTDGRFTGFIDCGRLGVADRYQDLALAARSLVHNFGESRCVAALFQRYGAVPDERRLAFYRLLDEFF	86.52	gnl|BL_ORD_ID|939|hsp_num:0	1018			84	279	neomycin; ribostamycin; butirosin; kanamycin A; gentamicin B; paromomycin; gentamicin
BGC0000145.1|Salinosporamide_25 # 31815 # 31922 # -1 # ID=1_25;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.713	BGC0000145.1|Salinosporamide_25 	31815	31922	-	Loose	300	21.557	tet(32)	44.44	3000196	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GTGACCGACCCGGTGCCCTGTGAGGCCGATCAGGGTGTCGCGGGCGGCGGCCTGCAACTGCCGGACGTGCCCGTGGGTGAAGGTGCGCAGGAACGAGCCGAGTGTTGA	MTDPVPCEADQGVAGGGLQLPDVPVGEGAQERAEC	MKIINIGILAHVDAGKTTLTESLLYTSGAIAEQGNVDKGTTRTDTMILERQRGITIQTAVTSFYWNDYKINIVDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMDIPTIIFINKIDQNGIDLQCVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIISGSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAIIETFITETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNGEIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREALLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIYLERPQKKASCTIHIEVPPNPFWASIGLTVTPLPVGSGTQYKSEVSLGYLNQSFQNAVMEGVRYGMEQGLYGWGVTDCQICFDYGVYYSPVSTPADFRFLAPVVLEQALKKAGTQLLEPYLSFTLFAPQEYLSRAYNDAPKYCAIIESTRLEKDEVIFKGEIPARCIGEYRNDLNFYTNGRSVCITELKGYQETSGEPVFQPRRPNSRLDKIRHMFQKIM	5.48	gnl|BL_ORD_ID|1220|hsp_num:0	1233			1335	1389	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000145.1|Salinosporamide_27 # 32503 # 32637 # 1 # ID=1_27;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.733	BGC0000145.1|Salinosporamide_27 	32503	32637	+	Loose	2300	23.483	Bacillus subtilis rpoB mutants conferring resistance to rifampin	41.18	3007073	protein variant model	S487L	R529S:627, S456L:624, S450L:1237	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGTTCGCCCGGCAGCACGATGATGCCGCCGAGTTCGACCACTGCCTCAGCCTGCTGGCCGCCGGCCCCGGCGGCGCCGCCGGGCTCCAGGTCGTCAACCGGGCGCTGCTGACCTACCTGCTCCCGAGGTCGAGG	MFARQHDDAAEFDHCLSLLAAGPGGAAGLQVVNRALLTYLLPRSR	MTGQLVQYGRHRQRRSYARISEVLELPNLIEIQTSSYQWFLDEGLREMFQDISPIEDFTGNLSLEFIDYSLGEPKYPVEESKERDVTYSAPLRVKVRLINKETGEVKDQDVFMGDFPIMTDTGTFIINGAERVIVSQLVRSPSVYFSGKVDKNGKKGFTATVIPNRGAWLEYETDAKDVVYVRIDRTRKLPVTVLLRALGFGSDQEILDLIGENEYLRNTLDKDNTENSDKALLEIYERLRPGEPPTVENAKSLLDSRFFDPKRYDLANVGRYKINKKLHIKNRLFNQRLAETLVDPETGEILAEKGQILDRRTLDKVLPYLENGIGFRKLYPNGGVVEDEVTLQSIKIFAPTDQEGEQVINVIGNAYIEEEIKNITPADIISSISYFFNLLHGVGDTDDIDHLGNRRLRSVGELLQNQFRIGLSRMERVVRERMSIQDTNTITPQQLINIRPVIASIKEFFGSSQLSQFMDQTNPLAELTHKRRLSALGPGGLTRERAGMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYAKVNRFGFIETPYRRVDPETGKVTGRIDYLTADEEDNYVVAQANARLDDEGAFIDDSIVARFRGENTVVSRNRVDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMQPEAPFVGTGMEYVSGKDSGAAVICKHPGIVERVEAKNVWVRRYEEVDGQKVKGNLDKYSLLKFVRSNQGTCYNQRPIVSVGDEVVKGEILADGPSMELGELALGRNVMVGFMTWDGYNYEDAIIMSERLVKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVGEDALRNLDDRGIIRIGAEVKDGDLLVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGGGGIIHDVKVFNREDGDELPPGVNQLVRVYIVQKRKISEGDKMAGRHGNKGVISKILPEEDMPYLPDGTPIDIMLNPLGVPSRMNIGQVLELHMGMAARYLGIHIASPVFDGAREEDVWETLEEAGMSRDAKTVLYDGRTGEPFDNRVSVGIMYMIKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEILTVKSDDVVGRVKTYEAIVKGDNVPEPGVPESFKVLIKELQSLGMDVKILSGDEEEIEMRDLEDEEDAKQADGLALSGDEEPEETASADVERDVVTKE	3.77	gnl|BL_ORD_ID|4771|hsp_num:0	5767			1407	1509	rifampin
